NMDA receptor antagonists impair prefrontal cortex function as assessed via spatial delayed alternation performance in rats: Modulation by dopamine

Journal of Neuroscience

Volumn 16, Issue 1, 1996, Pages 373-379

  Verma, Anita ^a   Moghaddam, Bita ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

antipsychotic drugs; delayed alternation; dopamine; glutamate; microdialysis; NMDA receptors; prefrontal cortex; schizophrenia

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DIZOCILPINE; DOPAMINE; DOPAMINE RECEPTOR BLOCKING AGENT; EXCITATORY AMINO ACID; HALOPERIDOL; KETAMINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; RACLOPRIDE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOPAMINE RELEASE; DOSE RESPONSE; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MAZE TEST; MICRODIALYSIS; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; SPATIAL DISCRIMINATION; TASK PERFORMANCE;

EID: 0030034191     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.16-01-00373.1996     Document Type: Article

References (69)

1. Akbarian S, Kim JJ, Potkin SG, Hagman JO, Tafazzoli A, Bunney WE, Jones EG (1995) Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch Gen Psychiatry 52:258-266.
2. Brito G, Thomas G, Davis B, Gingold S (1982) Prelimbic cortex, mediodorsal thalamus, septum, and delayed alternation in rats. Exp Brain Res 46:52-58.
3. Brozoski T, Brown R, Rosvold H, Goldman P (1979) Cognitive deficits produced by regional depletion of dopamine in prefrontal cortex of rhesus monkey. Science 205:929-932.
4. Butters N, Pandya D, Stein D, Rosen J (1972) A search for the spatial engram within the frontal lobes of monkeys Acta Neurobiol Exp Warsaw 32:305-329.
5. Chipkin R, Iorio L, Coffin V, McQuade R, Berger J, Barnett A (1988) Pharmacological profile of SCH 39166: a dopamine D1 selective benzonaphthaline with potent antipsychotic activity. J Pharmacol Exp Ther 247:1093-1102.
6. Christensen A, Arnt V, Hyttel J, Larsen J, Svendsen O (1984) Pharmacological effects of a specific dopamine D1-antagonist SCH 23390 in comparison with neuroleptics. Life Sci 34:1529-1540.
7. Clineschmidt BV, Martin GE, Bunting PR, Papp NL (1982) Central sympathomimetic activity of (+)-5-methyl-10,11-dihydro-5H-dibenzo(a,d)-cyclohepten-5,10-imine (MK 801), a substance with potent anticonvulsant, central sympathomimetic and apparent anxiolytic properties. Drug Dev Res 2:135-145.
8. Cohen M, Chan S, Bhargava H, Trevor A (1974) Inhibition of mammalian brain acetylcholinesterase by ketamine. Biochem Pharmacol 23:1647-1652.
9. 3H)-spiperone binding of 3,5-disubstitute N-((1-ethyl-2-pyrrolidinyl)methyl)-6-methoxy-salicylamides. J Med Chem 29:61-69.
10. Fitzgerald L, Deutch A, Gasic G, Heinemann S, Nestler E (1995) Regulation of cortical and subcortical glutamate receptor subunit expression by antipsychotic drugs. J Neurosci 15:2453-2461.
11. Freeman JJ, Stanton M (1992) Medial prefrontal cortex lesions and spatial delayed alternation in the developing rat: recovery or sparing? Behav Neurosci 106:924-932.
12. French E (1994) Phencyclidine and the midbrain dopamine system: electrophysiology and behavior. Neurotoxicol Teratol 16:355-362.
13. Fuster J (1980) The prefrontal cortex. New York: Raven.
14. Ghoneim M, Hinrichs J, Mewaldt S, Petersen R (1985) Ketamine: behavioral effects of subanesthetic doses. J Clin Psychopharmacol 5:70-77.
15. Goldman P, Rosvold H (1970) Localization of function within the dorsolateral prefrontal cortex of the rhesus monkey. Exp Neurol 27:291-304.
16. Goldman-Rakic PS (1987) Circuitry of the prefrontal cortex and the regulation of behaviour by representational knowledge. In: Handbook of physiology (Plum F, Mountcastle V, eds), pp 373-417. Bethesda, MD: American Physiological Society.
17. Goldman-Rakic PS (1991) Prefrontal cortical dysfunction in schizophrenia: the relevance of working memory. In: Psychopathology and the brain (Carroll BJ, Barrett JE, eds), pp 72-91. New York: Raven.
18. Gross C, Weiskrantz L (1964) Some changes in behavior produced by lateral frontal lesions in the macaque. In: The frontal granular cortex and behavior (Warren JM, Akert K, eds), pp 74-101. New York: McGraw-Hill.
19. Hall H, Sallemark M, Jerning E (1986) Effects of remoxipride and some related new substituted saclicymides on rat brain receptor. Acta Pharmacol Toxicol 58:61-70.
20. Harlow H, Davis R, Settlage P, Meyer D (1952) Analysis of frontal and posterior association syndromes in brain-damaged monkeys. J Comp Physiol Psychol 45:419-429.
21. Hondo H, Yonezawa Y, Nakahara T, Nakamura KHM, Mirano M, Uchimura H, Tashiro N (1994) Effects of phencyclidine on dopamine release in the rat prefrontal cortex: an in vivo microdialysis study. Brain Res 633:337-342.
22. Hyttel J (1983) SCH 23390: the first selective dopamine D1 antagonist Eur J Pharmacol 91:153-154.
23. Iorio L, Barnett A, Leitz F, House V, Korduba C (1983) SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems. J Pharmacol Exp Ther 226:462-468.
24. Irifune M, Shimizu T, Nomoto M (1991) Ketamine-induced hyperlocomotion associated with alternation of presynaptic components of dopamine neurons in the nucleus accumbens of mice. Pharmacol Biochem Behav 40:399-407.
25. Jacobsen C (1936) Studies of cerebral function in primates. Comp Psychol Monogr 13:1-68.
26. Javitt D, Zukin S (1991) Recent advances in phencyclidine model of schizophrenia. Am J Psychiatry 148:1-10.
27. Jedema H, Moghaddam B (1996) Characterization of excitatory amino acid modulation of dopamine release in the prefrontal cortex of conscious rats. J Neurochem, in press.
28. Kock W, Colpaert F, Woods J, Kamenka J-M (1989) The phencyclidine (PCP) analog N-[l-(2-benzo(b)thiophenyl)cydohexyl]pipendine shares cocaine-like but not other characteristic behavior effects with PCP, ketamine and MK-801. J Pharmacol Exp Ther 250:1019-1027.
29. 3H)-raclopride: a potent substituted benzamidine drug with high affinity for dopamine D2 receptors in the rat brain. Biochem Pharmacol 34:2251-2259.
30. Krystal J, Karper L, Seibyl J, Freeman G, Delaney R, Bremner J, Heninger G, Bowers M, Charney D (1994) Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Arch Gen Psychiatry 51:199-214.
31. Lapin IP, Rogawski MA (1992) Muscarinic antagonists attenuate dizocilpine-induced hypermotility in mice. Life Sci 50:59-64.
32. Loscher W, Honack D (1992) The behavioural effects of MK-801 in rats: involvement of dopaminergic, serotoninergic and noradrenergic systems. Eur J Pharmacol 215:199-208.
33. McCarthy G, Blamire A, Puce A, Nobre A, Bloch G, Hyder F, Goldman-Rakic PS, Shulman R (1994) Functional magnetic resonance imaging of human prefrontal cortex activation during a spatial working memory task. Proc Natl Acad Sci USA 91:8690-8694.
34. Memo M, Missale C, Carruba M, Spano P (1986) Pharmacology and biochemistry of dopamine receptors in the central nervous system and peripheral tissue. J Neural Transm 22:19-32.
35. Mishkin M (1964) Preservation of central sets after frontal lesions in monkeys. In: The frontal granular cortex and behavior (Warren JM, Akert K, eds), pp 219-241. New York: McGraw-Hill.
36. Mishkin M, Pribram K (1955) Analysis of the effects of frontal lesions in monkey. I. Variations on delayed alternation. J Comp Physiol Psychol 48:492-495.
37. Morris R, Anderson E, Lynch G, Baudry M (1986) Selective impairment of learning and blockade of long term potentiation by an N-methyl-D-aspartate antagonist, AP5. Nature 319:774-776.
38. Murphy BL, Roth RH, Arnsten AFT (1994) The effect of FG 7142 on prefrontal cortex dopamine and spatial working memory in rat and monkey. Soc Neurosci Abstr 24:416-421.
39. Oye N, Paulsen O, Maurset A (1992) Effects of ketamine on sensory perception: evidence for a role of N-methyl-D-aspartate receptors. J Pharmacol Exp Ther 260:1209-1213.
40. Parada-Turska J, Turski W (1990) Excitatory amino acid antagonists and memory: effect of drugs acting at N-methyl-D-aspartate receptors in learning and memory tasks. Neuropharmacology 29:1111-1116.
41. Parks S, Holzman P (1992) Schizophrenics show spatial working memory deficits. Arch Gen Psychiatry 49:975-982.
42. Passingham R (1975) Delayed matching after selective prefrontal lesions in monkeys (Macaca mulatta). Brain Res 92:89-102.
43. Paxinos G, Watson C (1982) The brain in stereotaxic coordinates. New York: Academic.
44. Rao T, Kim H, Lehman J, Martin L, Wood P (1989) Differential effects of phencyclidine (PCP) and ketamine on mesocortical and mesostriatal dopamine release in vivo. Life Sci 45:1065-1072.
45. Roberts A, De Salvia M, Wilkinson L, Collins P, Muir J, Everitt B, Robbins T (1994) 6-Hydroxydopamine lesions of the prefrontal cortex in monkeys enhance performance on an analog of the Wisconsin Card Sort Test: possible interactions with subcortical dopamine. J Neurosci 14:2531-2544.
46. Sawaguchi T, Goldman-Rakic PS (1991) D1 dopamine receptors in prefrontal cortex: involvement in working memory. Science 251:947-950.
47. Sawaguchi T, Goldman-Rakic PS (1994) The role of D1 dopamine receptor in working memory: local injections of dopamine antagonists into the prefrontal cortex of rhesus monkeys performing an oculomotor delayed-response task. J Neurophysiol 71:515-528.
48. Shapiro M, Caramano Z (1990) NMDA antagonist MK-801 impairs acquisition but not performance of spatial working and reference memory. Psychobiology 18:231-243.
49. Shi W-X, Bunney B (1994) Dopamine-induced depolarization of medial prefrontal cortical neurons. Soc Neurosci Abstr 20:1354.
50. Simon H, Scatton B, Le Moal M (1980) Dopaminergic A10 neurons are involved in cognitive functions. Nature 286:150-151.
51. Smiley J, Goldman-Rakic PS (1993) Heterogeneous targets of dopamine synapses in monkey prefrontal cortex demonstrated by serial section electron microscopy: a laminar analysis using the silver-enhanced diaminobenzidine sulfide (SEDS) immunolabeling technique. Cerebral Cortex 3:223-238.
52. Smiley J, Williams S, Szigeti K, Goldman-Rakic PS (1992) Light and electron microscopic characterization of dopamine-immunoreactive axons in human cerebral cortex. J Comp Neurol 321:325-335.
53. Smiley JF, Levey A, Ciliax B, Goldman-Rakic PS (1994) D1 dopamine receptor immunoreactivity in human and monkey cerebral cortex: predominant and extrasynaptic localization in dendritic spines. Proc Natl Acad Sci USA 91:5720-5724.
54. Smith D, Azzaro A, Zaldivar S, Palmer S, Lee H (1981) Properties of the optical isomers and metabolites of ketamine on the high affinity transport and catabolism of monoamines. Neuropharmacology 20:391-396.
55. Smith D, Westfall D, Adams J (1980) Ketamine interacts with opiate receptors as an agonist (Abstr). Anesthesiology 53A.
56. Sokoloff P, Giros B, Martres M-P, Bouthenet M-L, Schwartz J-C (1990) Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics. Nature 347:146-151.
57. Stam C, de Bruin J, van Haelst A, van der Gugten J, Kalsbeck A (1989) Influence of the mesocortical dopaminergic system on activity, food hoarding, social-agonistic behavior, and spatial delayed alternation in male rats. Behav Neurosci 103:24-35.
58. Stuss D, Benson D (1983) Frontal lobe lesions and behavior. Localization in neuropsychology (Kertesz A, ed), pp 429-454. New York: Academic.
59. Thomson A, West D, Lodge D (1985) An N-methyl-D-aspartate receptor-mediated synapse in rat cerebral cortex: a site of action of ketamine? Nature 313:479-481.
60. Taylor MA, Abrams R (1984) Cognitive impairment in schizophrenia. Am J Psychiatry 141:196-201
61. Uchihashi Y, Kuribara H, Isa Y, Morita T, Sato T (1994) The disruptive effects of ketamine on passive avoidance learning in mice: involvement of dopaminergic mechanisms. Psychopharmacology 116:40-44.
62. Uchihashi Y, Kuribara H, Morita T, Fujita T (1993) The repeated administration of ketamine induces an enhancement of its stimulant action in mice. Jpn J Pharmacol 61:149-151
63. Uchihashi Y, Kuribara H, Tadokoro S (1992) Assessment of the ambulation-increasing effect of ketamine by coadministration with central-acting drugs in mice. Jpn J Pharmacol 60:25-31.
64. Wedzony K, Klimek V, Golembiowska K (1993) MK-801 elevates the extracellular concentration of dopamine in the rat prefrontal cortex and increases the density of striatal dopamine D1 receptors. Brain Res 622:325-329.
65. Weinberger D (1987) Implication of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 44:660-669.
66. Weinberger D, Berman K, Zec R (1986) Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow (rCBF) evidence. Arch Gen Psychiatry 43:114-125.
67. Wesierska M, Macias-Gonzalez R, Bures J (1990) Differential effects of ketamine on the reference and working memory versions of the Morris water maze task. Behav Neurosci 104:74-83.
68. Wilcott R, Xuemei Q (1990) Delayed response, preoperative overtraining, and prefrontal lesions in the rat. Behav Neural Biol 53:393-401
69. Williams G, Goldman-Rakic PS (1995) Iontophoretic application of D1 receptor antagonists on prefrontal pyramidal neurons enhances neuronal memory fields associated with delayed response performance. Proc Natl Acad Sci USA 92:1111-1121.